A randomized, double‐blind, single‐dose study to assess bioequivalence of MB02 biosimilar after manufacturing iteration and reference bevacizumab

To investigate and compare the pharmacokinetic (PK) profiles of MB02 products, before and after optimizing the manufacturing process, and reference bevacizumab to establish bioequivalence between them. In this randomized, double‐blind, single dose, parallel study, 114 healthy male volunteers were ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwabe, C., Cole, A., Espigares‐Correa, A., Beydon, M. E., Florez‐Igual, A., Queiruga‐Parada, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011608/
https://www.ncbi.nlm.nih.gov/pubmed/36914963
http://dx.doi.org/10.1002/prp2.1070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011608/
https://www.ncbi.nlm.nih.gov/pubmed/36914963
http://dx.doi.org/10.1002/prp2.1070

Ejemplares similares